INSIGNEO ADVISORY SERVICES, LLC
Position in DFTX — Definium Therapeutics, Inc.
CIK 1964958
MIAMI, FL
Position in DFTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$298,280
New position
Shares Held
6,341
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#251
of 358 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026INSIGNEO ADVISORY SERVICES, LLC holds $3,685,699 across 13 Biotechnology names. DFTX ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
10,847 | $591,595 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
104,252 | $549,407 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
958 | $475,866 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
742 | $462,666 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
This page
|
6,341 | $298,280 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
1,010 | $287,819 | |
| 7 | INSM |
INSMED Inc
|
1,995 | $212,706 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
12,000 | $203,040 |
All Filings in DFTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $298,280 | 6,341 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||